
Kymera Therapeutics (NASDAQ:KYMR) Issues Quarterly Earnings Results
Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.97) earnings per share for the quarter, missing the consensus estimate of ($0.77) by ($0.20), FiscalAI reports. The business had revenue of $2.87 million for the quarter, compared to analyst estimates of $14.80 million. Kymera Therapeutics had a [...]









